#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell type acute leukaemia Parkinson's disease Prostate cancer Immunoglobulin G4 related disease Inflammatory myofibroblastic tumour Chronic myelomonocytic leukaemia Lupus nephritis Peripheral primitive neuroectodermal tumour of soft tissue Lennox-Gastaut syndrome Gastrooesophageal cancer Synovial sarcoma Optic glioma Blastic plasmacytoid dendritic cell neoplasia Oesophageal atresia Cerebral arteriovenous malformation haemorrhagic More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Treatment Factor IX deficiency – Trials in Disease Malignant fibrous histiocytoma – Trials in Disease Waldenstrom’s macroglobulinaemia Congenital generalised lipodystrophy Hepatic angiosarcoma – Life with Disease Mucopolysaccharidosis – Life with Disease Breast angiosarcoma – Diagnostics Krabbe’s disease – Life with Disease Ornithine transcarbamoylase deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Telitacicept Ralinepag Art0380 Mesilate Regadenoson Folic Acid Keto-Valine Calcium Lorazepam Bupivacaine Hydrochloride Piperacillin Monohydrate Azithromycin Dihydrate Omp11 Bosentan Esomeprazole CC-97540 Ceftazidime Pentahydrate Ribociclib Aflibercept Sertraline Opium, Standardized Powdered Nazartinib More therapies…

    Learn about Your Condition

    Post procedural hypotension Liver transplant Breast cancer metastatic Intestinal ischaemia Microvillous inclusion disease Systemic scleroderma Bipolar I disorder ROHHAD syndrome Wiskott-Aldrich syndrome Laryngeal leukoplakia Spina bifida Malignant melanoma stage III Varices oesophageal Tonsillitis Von Hippel-Lindau disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Central nervous system lymphoma
    Investigated Drugs:
    • Rituximab
    • Temozolomide
    Austria Belgium Czechia France Germany Hungary +3

  • AUR200 for Patients with Generalized Myasthenia Gravis

    Recruiting

    1 1 1
    Investigated Drugs:
    • AUR200
    • Sodium Chloride
    Poland

  • Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • 2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione
    Belgium Czechia Denmark France Germany Italy +1

  • VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • VMX-C001
    Austria Belgium Bulgaria Czechia Estonia France +9

  • ICP-332 for Adults with Prurigo Nodularis

    Recruiting

    2 1
    Investigated Diseases:
    • Neurodermatitis
    Austria Belgium France Germany Poland

  • Study on Brimonidine Eye Drops to Prevent Myopia Progression in Children Aged 6 to 14 Years

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Brimonidine Tartrate
    Spain
Previous Page
1 … 639 640 641 642 643 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!